Advanced search Help
Clear all search criteria
Only 2/3! You are seeing results from the Public Collection, not the complete Full Collection. Sign in to search everything (see eligibility).
-
Fact Sheet for Healthcare Providers: Compass Laboratory Services SARS-CoV2 Assay - Compass Laboratory Services, LLC
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Compass Laboratory Services SARS-CoV2 [severe acute respiratory syndrome coronavirus 2] Assay that has been issued an Emergency Use Authorization (EUA) by FDA. The Compass Laboratory Services SARS-CoV2 Assay is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider or self-collected using a home collection kit specified in the test's labeling."
United States. Food and Drug Administration
2020-07-13
-
Fact Sheet for Healthcare Providers: 'PhoenixDx SARS-CoV-2 Multiplex' - Trax Management Services Inc.
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the 'PhoenixDx SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] Multiplex'. The 'PhoenixDx SARS-CoV-2 Multiplex' is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider."
United States. Food and Drug Administration
2020-07-13
-
Coronavirus (COVID-19) Pandemic: Personal Protective Equipment Preservation Best Practices [July 13, 2020]
From the Document: "This fact sheet summarizes best practices for national implementation to sustain personal protective equipment (PPE) while ensuring the protection of healthcare personnel (HCP) and first responders during the coronavirus (COVID-19) pandemic response."
United States. Federal Emergency Management Agency; United States. Department of Health and Human Services
2020-07-13
-
Eurasian Avian-Like A(H1N1) Swine Influenza Viruses
From the Event Background: "The 2009 pandemic was the latest of several pandemics caused by a swine-origin influenza virus. Swine influenza is not a mandatory notifiable disease according to the World Organisation for Animal Health (OIE) criteria for disease notification. A recently published study conducted between 2011 and 2018 in China, and based on surveillance data in pigs, identified an emerging genotype 4 (G4) reassortant Eurasian avian-like (EA) A(H1N1) swine influenza virus that contains internal genes from the human A(H1N1)pdm09 and North American triple-reassortant (TR) lineage-derived internal genes. This virus demonstrated the ability to replicate in human epithelial cells and can spread through respiratory droplets between ferrets. Antisera against seasonal human A(H1N1)pdm09 virus showed poor reactivity with G4 viruses. In the same study, a subsequent serosurvey found that 10% (35/338) of swine farm workers were positive for this G4 EA A(H1N1) virus, with a higher proportion in people between 18 and 35 years of age (21%; 9/44). These findings raise concern about the pandemic potential of these viruses, which are already able to replicate successfully in human tissue and transmit through droplets between ferrets, being a model for human-to-human transmission."
European Centre for Disease Prevention and Control
2020-07-13
-
Fact Sheet for Healthcare Providers: Salofa Oy, Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette
From the Document: "This fact sheet informs you of the significant known and potential risks and benefits of the emergency use of the Sienna-Clarity COVIBLOCK COVID-19 [coronavirus disease 2019] IgG/IgM [Immunoglobulin G/Immunoglobulin M] Rapid Test Cassette. This test is authorized for the detection of antibodies to SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] in human serum, plasma (dipotassium EDTA [ethylenediaminetetraacetic acid], sodium citrate, sodium heparin) and venous whole blood (dipotassium EDTA, sodium citrate, sodium heparin)."
United States. Food and Drug Administration
2020-07-13
-
Global COVID-19 Clinical Platform: Rapid Core Case Report Form (CRF)
From the Document: "In response to the COVID-19 [coronavirus disease 2019] pandemic, the World Health Organization (WHO) has launched a global COVID-19 anonymized clinical data platform (the 'COVID-19 Data Platform') to enable State Parties to the International Health Regulations (IHR) (2005) to share with WHO anonymized clinical data related to patients with suspected or confirmed infections with SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] (collectively 'anonymized COVID-19 data'). The anonymized COVID-19 data received by WHO will remain the property of the contributing Entity and will be used by WHO for purposes of verification, assessment and assistance pursuant to the IHR (2005), including to inform the public health and clinical operation response in connection with the COVID-19 outbreak. To help achieve these objectives, WHO has established an independent Clinical Advisory Group to advise WHO on global reporting and analysis of the anonymized clinical COVID-19 data. State Parties and other entities are invited to contact WHO to obtain more information about how to contribute anonymized clinical COVID-19 data to the WHO Data Platform. To preserve the security and confidentiality of the anonymized COVID-19 data, State Parties and other entities are respectfully requested to take all necessary measures to protect their respective log-in credentials and passwords to the COVID-19 Data Platform."
World Health Organization
2020-07-13
-
FEMA's Community Disaster Loan (CDL) Program: A Primer [July 13, 2020]
From the Document: "Following a major disaster, local governments may face fiscal and economic distress as well as physical damage. As a result, revenue shortfalls could impact both service delivery and the long-term fiscal health in the affected locality. To address these issues, the Federal Emergency Management Agency (FEMA) offers the Community Disaster Loan (CDL) program, which provides forgivable loans capped at $5 million to units of local government based on real revenue shortfalls. This In Focus examines the basic structure of the CDL program and also briefly considers two CDL variants developed in response to distinct disaster situations."
Library of Congress. Congressional Research Service
Cecire, Michael H.
2020-07-13
-
Guyana: An Overview [Updated July 13, 2020]
From the Document: "Located on the north coast of South America, English-speaking Guyana has characteristics of a Caribbean nation because of its British colonial heritage (the country became independent in 1966). Guyana participates in Caribbean regional organizations, and its capital Georgetown serves as headquarters for the Caribbean Community (CARICOM), a regional integration organization."
Library of Congress. Congressional Research Service
Sullivan, Mark P.
2020-07-13
-
Global COVID-19 Clinical Platform with Pregnancy Module -- CRF-P
From the Introduction: "In response to the COVID-19 [coronavirus disease 2019] pandemic, the World Health Organization (WHO) has launched a global COVID-19 anonymized clinical data platform (the 'COVID-19 Data Platform') to enable State Parties to the International Health Regulations (IHR) (2005) to share with WHO anonymized clinical data related to patients with suspected or confirmed infections with SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] (collectively 'anonymized COVID-19 data'). The anonymized COVID-19 data received by WHO will remain the property of the contributing Entity and will be used by WHO for purposes of verification, assessment and assistance pursuant to the IHR (2005), including to inform the public health and clinical operation response in connection with the COVID-19 outbreak. To help achieve these objectives, WHO has established an independent Clinical Advisory Group to advise WHO on global reporting and analysis of the anonymized clinical COVID-19 data. State Parties and other entities are invited to contact WHO to obtain more information about how to contribute anonymized clinical COVID-19 data to the WHO Data Platform. To preserve the security and confidentiality of the anonymized COVID-19 data, State Parties and other entities are respectfully requested to take all necessary measures to protect their respective log-in credentials and passwords to the COVID-19 Data Platform."
World Health Organization
2020-07-13
-
Fact Sheet for Healthcare Providers: PowerChek 2019-nCoV Real-time PCR Kit - KogeneBiotech Co., Ltd.
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the PowerChek 2019-nCoV [novel coronavirus] Real-time PCR [polymerase chain reaction] Kit. The PowerChek 2019-nCoV Real-time PCR Kit is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider."
United States. Food and Drug Administration
2020-07-13
-
Rapid Gender Analysis: COVID-19 in the United States
From the Executive Summary: "The United States, one of the wealthiest countries in the world, also has the highest number of cases of COVID-19 [coronavirus disease 2019] in the world, far surpassing global hotspots like Italy and China, with cases continuing to rise at concerning rates. In this humanitarian crisis, CARE is bringing its global expertise--from more than 75 years of implementing humanitarian responses in more than 100 countries--to the context of COVID-19 in the United States. In addition to its expertise in humanitarian and crisis response, CARE developed the industry-standard Rapid Gender Analysis (RGA) that builds upon several efforts by humanitarian actors to bring gender to the forefront of programming. The standardized tool to enable humanitarian actors to quickly build crisis responses that take into account the different needs of people of all genders, as well as disenfranchised groups, the extreme poor, and other groups often overlooked by policy, crisis planning, and data."
CARE/International
Kalyanpur, Anushka; Thomas, Dannielle; Wu, Diana . . .
2020-07-13
-
Key Considerations for Transferring Patients to Relief Healthcare Facilities When Responding to Community Transmission of COVID-19 in the United States
From the Document: "Many COVID-19 [coronavirus disease 2019] cases are geographically localized and can overwhelm local healthcare facilities. This means that healthcare systems typically have uneven distribution of COVID-19 cases, with some regions' healthcare systems experiencing patient surges while others have excess capacity for patient care. When healthcare facilities reach or exceed patient capacity, crisis standards of care are often implemented. Healthcare systems entering crisis standards of care are faced with the tremendous challenge of providing high-quality care while allocating scarce resources. [...] This guidance is for state and local emergency medical planners and all healthcare facilities, especially facilities in rural areas. This guidance outlines considerations around the transfer of patients, staff, and supplies between healthcare facilities to optimize patient care, balance resources, and minimize use of crisis care standards."
Centers for Disease Control and Prevention (U.S.)
2020-07-12
-
MMWR: Morbidity and Mortality Weekly Report, July 10, 2020
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). [It] is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. This issue of MMWR contains the following: "Increases in Health-Related Workplace Absenteeism Among Workers in Essential Critical Infrastructure Occupations During the COVID-19 [coronavirus disease 2019] Pandemic -- United States, March-April 2020"; "Provision of Pediatric Immunization Services During the COVID-19 Pandemic: an Assessment of Capacity Among Pediatric Immunization Providers Participating in the Vaccines for Children Program -- United States, May 2020"; "Race/Ethnicity, Underlying Medical Conditions, Homelessness, and Hospitalization Status of Adult Patients with COVID-19 at an Urban Safety-Net Medical Center -- Boston, Massachusetts, 2020"; "Trends in Emergency Department Visits for Contact Sports-Related Traumatic Brain Injuries Among Children -- United States, 2001-2018"; "Trends in Nonfatal Falls and Fall-Related Injuries Among Adults Aged ≥65 Years -- United States, 2012-2018"; "Initial and Repeated Point Prevalence Surveys to Inform SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] Infection Prevention in 26 Skilled Nursing Facilities -- Detroit, Michigan, March-May 2020"; and "Update: COVID-19 Among Workers in Meat and Poultry Processing Facilities -- United States, April-May 2020."
Centers for Disease Control and Prevention (U.S.)
2020-07-10
-
Latin America and the Caribbean: Impact of COVID-19 [Updated July 10, 2020]
From the Document: "The Coronavirus Disease 2019 (COVID-19) pandemic is having widespread economic, social, and political effects on Latin America and the Caribbean, a region with strong congressional interest because of deep U.S. linkages. As of July 10, 2020, the region had almost 3.2 million confirmed cases and over 138,000 deaths, with deaths surging in several countries. Brazil, Mexico, Peru, Chile, and Ecuador have the highest numbers of deaths in the region, and Brazil has the highest number worldwide after the United States."
Library of Congress. Congressional Research Service
Sullivan, Mark P.; Beittel, June S.; Meyer, Peter J. . . .
2020-07-10
-
COVID-19 Guidance for Hospital Reporting and FAQs for Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting, Updated July 10, 2020
From the Document: "On March 29, 2020, Vice President Pence sent a letter to hospital administrators across the country requesting daily data reports on testing, capacity and utilization, and patient flows to facilitate the public health response to the 2019 Novel Coronavirus (COVID-19). Many separate governmental entities are requesting similar information, resulting in stakeholder requests to reduce duplication and minimize reporting burden. This document details the Federal Government's data needs, explains the division of reporting responsibility between hospitals and states, and provides clear, flexible options for the timely delivery of this critical information. The objective is to allow states and hospitals either to leverage existing data reporting capabilities or, where those capabilities are insufficient, to provide guidance in how to build upon existing capabilities."
United States. Department of Health and Human Services
2020-07-10
-
Early Warning Audit of FEMA Public Assistance Grants to Collier County, Florida
From the Document: "The DHS Office of Inspector General contracted with Cotton & Company LLP [limited liability partnership] to conduct an audit to determine whether FEMA ensured that the recipient (FDEM) and its subrecipient (the County) established and implemented policies, procedures, and practices to ensure that PA grant funds awarded to disaster areas are accounted for and expended in accordance with Federal regulations and FEMA guidance."
United States. Department of Homeland Security. Office of Inspector General
2020-07-10
-
Police Use of Force: Overview and Considerations for Congress [July 10, 2020]
From the Document: "Recent events have focused congressional attention on the policing practices of federal, state, and local law enforcement officers. One area of particular focus has been police use of force against criminal suspects. Currently, the federal government collects some data on state and local police use of force, but substantive standards on law enforcement use of force in general do not exist in federal statute. Rather, the applicable legal standards for permissible use of force are a function of the Fourth Amendment's prohibition on 'unreasonable … seizures.' Violations of constitutional excessive force standards can be enforced through various federal criminal and civil provisions and are often incorporated into (and in some cases elaborated on by) jurisdiction- or agency-specific use-of-force policies and state statutes. Scholars and commentators have debated for years how meaningful current standards are in cabining law enforcement use of force. Amid recent reform efforts, a legislative proposal passed by the House--the George Floyd Justice in Policing Act of 2020 (Justice in Policing Act)--would make changes to current use-of-force doctrine. A separate proposal in the Senate, the Just and Unifying Solutions to Invigorate Communities Everywhere Act of 2020 (JUSTICE Act), would supplement existing standards in narrower circumstances. This Sidebar provides an overview of Fourth Amendment use-of-force doctrine, briefly surveys some of the standards and variations in current use-of-force policies, and examines how the Justice in Policing Act and the JUSTICE Act would alter police use of force."
Library of Congress. Congressional Research Service
Foster, Michael A. (Legislative attorney)
2020-07-10
-
Supreme Court Clarifies Rules for Electoral College: States May Restrict Faithless Electors [July 10, 2020]
From the Document: "On July 6, 2020, the Supreme Court unanimously held that states may punish or replace presidential electors who refuse to cast their ballots for the candidate chosen by the voters of their state. In the case 'Chiafalo v. Washington,' a majority of the Court held that the State of Washington's constitutional authority to appoint electors includes the power to impose a $1,000 fine against electors who violate their pledge to support the candidate chosen in the state's popular vote. In the related case 'Colorado Department of State v. Baca,' the Court upheld on the same grounds Colorado's policy of replacing electors who attempt to cast a ballot for a person who did not win the state's popular vote. This Legal Sidebar explains the Court's decisions and reviews their broader implications."
Library of Congress. Congressional Research Service
Shelly, Jacob D.
2020-07-10
-
SBA EIDL and Emergency EIDL Grants: Data by State [Updated July 10, 2020]
From the Document: "Congress made COVID-19 [coronavirus disease 2019]-related economy injury an eligible expense for the Small Business Administration's (SBA) Economic Injury Disaster Loans (EIDL) in the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123). It also expanded EIDL eligibility for certain businesses and organizations, and it established an Emergency EIDL Grant program as part of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act; P.L. 116-136). COVID-19-related EIDL and Emergency EIDL grants are available to all 50 states, U.S. territories, and Washington, DC. This Insight provides [1] a general overview of SBA EIDL (including eligibility) and the Emergency EIDL Grant program; [2] SBA EIDL data by the number and amount of loans approved by state; and [3] Emergency EIDL Grant program (also referred to as EIDL advance) data by the number and amount of grants approved by state."
Library of Congress. Congressional Research Service
Lindsay, Bruce R.; Mullins, Maura
2020-07-10
-
Trump v. Mazars: Implications for Congressional Oversight [July 10, 2020]
From the Document: "On July 9, 2020, the Supreme Court issued a pair of decisions concerning subpoenas seeking access to the President's personal financial records, including tax returns. In 'Trump v. Vance,' the Court ruled that the President is not categorically 'immune from state criminal subpoenas seeking his private papers.' Nor does a 'heightened showing of need' have to be made before a state grand jury subpoena can be issued for a sitting President's personal records. Thus, the President, though able to present some defenses that are unique to his office, is otherwise treated much like 'every man' when called upon to produce evidence in a criminal proceeding. Not entirely so, however, in a congressional investigation. In 'Trump v. Mazars,' the Supreme Court vacated appellate court opinions directing compliance with congressional subpoenas for the President's personal financial records, holding that those courts had not sufficiently considered the 'weighty' separation of powers concerns specifically implicated by congressional subpoenas 'directed at the President's personal information.' The 7-2 decision clarified that, as in 'Vance,' the President is not entirely immune from congressional process, but nevertheless laid out four 'special considerations' that must inform an appropriately 'balanced' and 'careful analysis' that is triggered when Congress seeks the President's personal records. The Court then remanded, directing the lower courts to apply those considerations, and possibly others, to the specific subpoenas. Although giving guidance, the 'Mazars' Court left the question of whether the President must comply with the congressional subpoenas for another day."
Library of Congress. Congressional Research Service
Garvey, Todd
2020-07-10
-
Army's Armored Multi-Purpose Vehicle (AMPV): Background and Issues for Congress [Updated July 10, 2020]
From the Summary: "The Armored Multi-Purpose Vehicle (AMPV) is the Army's replacement for the Vietnam-era M113 personnel carriers, which are still in service in a variety of support capacities in Armored Brigade Combat Teams (ABCTs). While M-113s no longer serve as infantry fighting vehicles, five variants of the M-113 are used as command and control vehicles, general purpose vehicles, mortar carriers, and medical treatment and evacuation vehicles."
Library of Congress. Congressional Research Service
Feickert, Andrew
2020-07-10
-
Motor Vehicle Safety: Issues for Congress [Updated July 10, 2020]
From the Summary: "Vehicle safety is a significant issue as Congress considers a replacement for the current authorization of surface transportation programs, the Fixing America's Surface Transportation Act (FAST Act; P.L. 114-94), which expires at the end of FY2020. On July 1, 2020, the House of Representatives passed an infrastructure and surface transportation bill, the Moving Forward Act (H.R. 2), including provisions that seek to improve motor vehicle safety. A corresponding bill has not advanced in the Senate. Responsibility for motor vehicle safety lies with the National Highway Traffic Safety Administration (NHTSA) within the U.S. Department of Transportation (DOT). The agency's performance has been controversial, in part because of its handling of the largest-ever recall, involving more than 63 million Takata airbags; since the recall was ordered in 2015, nearly 16 million potentially defective airbags have not been replaced. NHTSA has been without a Senate-confirmed administrator since 2017."
Library of Congress. Congressional Research Service
Canis, Bill
2020-07-10
-
International Emergency Economic Powers Act: Key Facts [Updated July 10, 2020] [infographic]
From the Document: "[1] In the 1970s, Congress enacted the National Emergencies Act (NEA) and IEEPA [International Emergency Economic Powers Act] to replace previous emergency authorities and place new limits on presidential emergency power. [2] Since the enactment of the NEA and IEEPA, Presidents have declared 67 national emergencies. [3] Since 1995, 40 national emergencies citing IEEPA have been declared, 9 have ended. [4] Presidents have declared national emergencies invoking IEEPA with respect to 35 countries as part of the U.S. sanctions regime. [5] IEEPA was used to continue enforcement of the Export Administration Act (EAA) upon its expiration 6 times for a total of 27 years. IEEPA authority is still used to continue certain export controls related to WMD [weapons of mass destruction]."
Library of Congress. Congressional Research Service
Casey, Christopher A.
2020-07-10
-
Fact Sheet for Healthcare Providers: Emergency Use of GammaCore Sapphire CV During the COVID-19 Pandemic
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the gammaCore Sapphire CV during the Coronavirus Disease 2019 (COVID-19) pandemic. Early reports of COVID-19 infections demonstrate a high level of aggressive, prolonged inflammation in the airways which may result in significant worsening of asthma-related symptoms in the large adult asthmatic population. The gammaCore Sapphire CV is intended for acute use at home or in healthcare settings to treat adult patients with known or suspected COVID-19 who are experiencing exacerbation of asthma-related dyspnea and reduced airflow, and for whom approved drug therapies are not tolerated or provide insufficient symptom relief as assessed by their healthcare provider, using noninvasive vagus nerve stimulation (VNS) on either side of the patient's neck during the (COVID-19) pandemic."
United States. Food and Drug Administration
2020-07-10
-
Immigration: 'Recalcitrant' Countries and the Use of Visa Sanctions to Encourage Cooperation with Alien Removals [Updated July 10, 2020]
From the Document: "The ability to repatriate foreign nationals (aliens) who violate U.S. immigration law is central to the immigration enforcement system. The Immigration and Nationality Act (INA) provides broad authority to the Department of Homeland Security (DHS) and the Department of Justice (DOJ) to remove certain foreign nationals from the United States."
Library of Congress. Congressional Research Service
Wilson, Jill, 1974-
2020-07-10
-
Spread of Coronavirus and Racial Disparities
From the Document: "As the coronavirus began to spread through the United States, it became clear that the pandemic was taking a particularly hard toll on communities of color, both medically and financially. There are numerous reasons for this disparate impact, and it's worth surveying some of the data around it. A better understanding of the coronavirus's impact can help guide effective policymaking going forward. As detailed here, the virus and economic fallout were simultaneously highlighting and exacerbating existing disparities. Two studies have recently identified the use of public transportation as a primary culprit of the increased rates of infections: Many essential workers, unable to work from home, are minorities and more likely to rely on public transit to get to work. The combination of being at work and riding public transportation significantly increases the risk of exposure to the virus."
American Action Forum
O'Neill Hayes, Tara
2020-07-10
-
WHO Mass Gathering COVID-19 Risk Assessment Tool -- Generic Events
From the Document: "The content of this Risk Assessment tool has been updated to reflect new WHO [World Health Organization] guidance and new evidence on both COVID-19 [coronavirus disease 2019] and mass gatherings, as well as feedback from end-users. Additional improvements have been made to the way the information is organized and presented: the Decision Tree is now built into the tool and a new tab dedicated to Risk Communication has been added. The expanded tool now includes six tabs: 1. Instructions; 2. Decision Tree; 3. Risk Evaluation; 4. Risk Mitigation; 5. Decision Matrix; 6. Risk Communication."
World Health Organization
2020-07-10
-
WHO Mass Gathering COVID-19 Risk Assessment Tool -- Religious Events
From the Document: "Routine planning for mass gatherings includes conducting risk assessments to determine the overall risk of disease spread connected to a mass gathering. In view of the current outbreak of COVID-19 [coronavirus disease 2019], the World Health Organization (WHO) has developed this risk assessment tool for religious events. The assessment include a risk evaluation, risk mitigation, and risk communication strategy developed for use by host countries and organizers of mass gathering to assess the specific risk of COVID-19."
World Health Organization
2020-07-10
-
WHO Mass Gathering COVID-19 Risk Assessment Tool -- Sports Events
From the Document: "The content of this Risk Assessment tool has been updated to reflect new WHO [World Health Organization] guidance and new evidence on both COVID-19 [coronavirus disease 2019] and mass gatherings, as well as feedback from end-users. Additional improvements have been made to the way the information is organized and presented: the Decision Tree is now built into the tool and a new tab dedicated to Risk Communication has been added. The expanded tool now includes six tabs: 1. Instructions; 2. Decision Tree; 3. Risk Evaluation; 4. Risk Mitigation; 5. Decision Matrix; 6. Risk Communication."
World Health Organization
2020-07-10
-
Fact Sheet for Healthcare Providers: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. WANTAI SARS-CoV-2 Ab Rapid Test
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the WANTAI SARS-CoV-2 Ab [severe acute respiratory syndrome coronavirus 2 antibody] Rapid Test. The WANTAI SARS-CoV-2 Ab Rapid Test is authorized for the detection of total antibodies to SARS-CoV-2 in human serum, plasma (EDTA [ethylenediaminetetraacetic acid], lithium heparin, and sodium citrate) and venous whole blood."
United States. Food and Drug Administration
2020-07-10
